Page last updated: 2024-09-03

annamycin and Carcinoma, Small Cell

annamycin has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Doyle, LA; Ling, YH; Neamati, N; Perez-Soler, R; Priebe, W; Schneider, E; Zou, Y1

Other Studies

1 other study(ies) available for annamycin and Carcinoma, Small Cell

ArticleYear
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
    International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1

    Topics: Antibiotics, Antineoplastic; ATP-Binding Cassette Transporters; Blotting, Western; Breast Neoplasms; Carcinoma, Small Cell; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured

1997